Johnson & Johnson
Johnson and Johnson: Q4, courtrooms and cutting-edge science
Johnson & Johnson excels in advancing medical innovation while adeptly handling market and legal challenges.
Johnson & Johnson Ordered to Pay $18.8 Million in Talc Cancer Suit
This week, the company also filed a separate but unrelated lawsuit against the Biden Administration.
Johnson & Johnson entrenará a estudiantes y médicos mexicanos en el metaverso
La empresa estrena un Innovation Room con tecnología de punta que demuestra el uso académico que se le puede dar a los visores inmersivos que sirven para acceder al metaverso.
Johnson & Johnson will train Mexican students and doctors in the metaverse
The company launches an Innovation Room with state-of-the-art technology that demonstrates the academic use that can be given to immersive viewers that serve to access the metaverse.
Johnson & Johnson Will Split Into 2 Companies
The move will separate Johnson & Johnson's consumer health brands from the rest of the company's offerings.
Johnson & Johnson Hit With More Than $1 Billion Verdict on Hip Implants
The hip implants were defectively designed and the company failed to warn consumers about the risks.
J&J to Buy Hair Care Products Maker Vogue for $3.3 Billion
The transaction, slated to close in the third quarter, is not expected to have an impact on the company's 2016 sales or earnings forecasts.
Big Business or Small, I'm Still an Entrepreneur
I'm no different running a 20-person shop as I am many multiples of that.
Johnson & Johnson Ordered to Pay $55 Million in Talc-Powder Trial
The company had lost a previous trial and faces approximately 1,200 lawsuits accusing it of not adequately warning consumers about its talc-based products' cancer risks.
The Verdict Against Johnson & Johnson Doesn't Mean More Judgements Will Follow
While Jacqueline Fox's family won $72 million in damages this week, not all plaintiffs in the 1,200 similar pending talc powder-cancer cases will be cashing in.
Johnson & Johnson to Cut 3,000 jobs in Medical Devices Division
The company said the restructuring would affect its orthopaedics, surgery and cardiovascular businesses within the larger medical devices unit.